KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Bausch Health Companies (BHC) over the last 12 years, with Q3 2025 value amounting to $1.0 million.

  • Bausch Health Companies' Asset Writedowns and Impairment changed N/A to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $29.0 million for FY2024, which is 4629.63% down from last year.
  • Bausch Health Companies' Asset Writedowns and Impairment amounted to $1.0 million in Q3 2025.
  • In the past 5 years, Bausch Health Companies' Asset Writedowns and Impairment registered a high of $148.0 million during Q1 2021, and its lowest value of $1.0 million during Q3 2022.
  • Its 5-year average for Asset Writedowns and Impairment is $23.8 million, with a median of $10.5 million in 2022.
  • In the last 5 years, Bausch Health Companies' Asset Writedowns and Impairment soared by 460000.0% in 2021 and then crashed by 9459.46% in 2022.
  • Quarter analysis of 5 years shows Bausch Health Companies' Asset Writedowns and Impairment stood at $21.0 million in 2021, then tumbled by 95.24% to $1.0 million in 2022, then soared by 300.0% to $4.0 million in 2023, then soared by 475.0% to $23.0 million in 2024, then plummeted by 95.65% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $23.0 million for Q4 2024, and $5.0 million during Q2 2024.